Cargando…

Performance of a Smart Device over 12-Months for Home Monitoring of Patients with Intermediate Age-Related Macular Degeneration

Background: To determine the 12-month compliance with and retention of home monitoring (HM) with Melbourne Rapid Fields (MRFh) for patients with intermediate age-related macular degeneration (iAMD) and compare visual acuity (VA) and retinal sensitivity (RS) results to clinical measures. Methods: Par...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prea, Selwyn, Guymer, Robyn, Kong, George, Vingrys, Algis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095505/ https://www.ncbi.nlm.nih.gov/pubmed/37048613 http://dx.doi.org/10.3390/jcm12072530

Ejemplares similares

Test Reliability and Compliance to a Twelve-Month Visual Field Telemedicine Study in Glaucoma Patients
por: Prea, Selwyn Marc, et al.
Publicado: (2022)

Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
por: Prea, Selwyn M., et al.
Publicado: (2015)

Scaling the size of perimetric stimuli reduces variability and returns constant thresholds across the visual field
por: Bedggood, Phillip, et al.
Publicado: (2021)

Home Monitoring of Retinal Sensitivity on a Tablet Device in Intermediate Age-Related Macular Degeneration
por: Adams, Matthew, et al.
Publicado: (2018)

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
por: Lad, Eleonora M., et al.
Publicado: (2023)

Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)
por: Guymer, Robyn H, et al.
Publicado: (2008)

Comparison of Visual Function Tests in Intermediate Age-Related Macular Degeneration
por: Guymer, Robyn H., et al.
Publicado: (2021)

Exploring Reticular Pseudodrusen Extent and Impact on Mesopic Visual Sensitivity in Intermediate Age-Related Macular Degeneration
por: Kumar, Himeesh, et al.
Publicado: (2022)

Presymptomatic Retinal Sensitivity Changes in Intermediate Age-Related Macular Degeneration Associated With New Retinal Fluid
por: Wightman, Antony J., et al.
Publicado: (2019)

Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
por: Hurley, Susan F, et al.
Publicado: (2008)

Cost-effectiveness of smoking cessation to prevent age-related macular degeneration
por: Hurley, Susan F, et al.
Publicado: (2008)

Properties of the Impact of Vision Impairment and Night Vision Questionnaires Among People With Intermediate Age-Related Macular Degeneration
por: McGuinness, Myra B., et al.
Publicado: (2019)

Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion
por: Bhandari, Sanjeeb, et al.
Publicado: (2022)

Subthreshold Nano-Second Laser Treatment and Age-Related Macular Degeneration
por: Cohn, Amy C., et al.
Publicado: (2021)

Role of sleep-disordered breathing in age-related macular degeneration
por: Fang, Wendy Ying, et al.
Publicado: (2023)

New Technologies to Study Functional Genomics of Age-Related Macular Degeneration
por: Nguyen, Tu, et al.
Publicado: (2021)

Repeatability of Retinal Sensitivity Measurements Using a Medmont Dark-Adapted Chromatic Perimeter in Healthy and Age-Related Macular Degeneration Cases
por: Tan, Rose S., et al.
Publicado: (2018)

Home Monitoring of Age-Related Macular Degeneration: Utility of the ForeseeHome Device for Detection of Neovascularization
por: Yu, Hannah J., et al.
Publicado: (2020)

Photoreceptor alteration in intermediate age-related macular degeneration
por: Borrelli, Enrico, et al.
Publicado: (2020)

Choroidal Vascular Impairment in Intermediate Age-Related Macular Degeneration
por: Flores, Rita, et al.
Publicado: (2022)

Characteristics of intermediate age-related macular degeneration with hyperreflective foci
por: Kikushima, Wataru, et al.
Publicado: (2022)

Comprehensive Analysis of Copy Number Variation of Genes at Chromosome 1 and 10 Loci Associated with Late Age Related Macular Degeneration
por: Cantsilieris, Stuart, et al.
Publicado: (2012)

Natural History of Rod-Mediated Dark Adaptation over 2 Years in Intermediate Age-Related Macular Degeneration
por: Owsley, Cynthia, et al.
Publicado: (2017)

Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
por: Chan, Clement K., et al.
Publicado: (2023)

Relationship Between Rod-Mediated Sensitivity, Low-Luminance Visual Acuity, and Night Vision Questionnaire in Age-Related Macular Degeneration
por: McGuinness, Myra B., et al.
Publicado: (2020)

Early and intermediate age-related macular degeneration: update and clinical review
por: García-Layana, Alfredo, et al.
Publicado: (2017)

Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients
por: Mitchell, Sabrina L., et al.
Publicado: (2021)

Retinal Progression Biomarkers of Early and Intermediate Age-Related Macular Degeneration
por: Flores, Rita, et al.
Publicado: (2021)

Identifying Imaging Predictors of Intermediate Age-Related Macular Degeneration Progression
por: Flores, Rita, et al.
Publicado: (2023)

Oral Omega-3 Supplementation Lowers Intraocular Pressure in Normotensive Adults
por: Downie, Laura Elizabeth, et al.
Publicado: (2018)

The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study
por: Arnold, Jennifer J., et al.
Publicado: (2016)

Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration
por: Barthelmes, Daniel, et al.
Publicado: (2016)

Effectiveness of ranibizumab intravitreal injections for exudative age-related macular degeneration treatment: 12-month outcomes
por: Figurska, Małgorzata, et al.
Publicado: (2011)

A Tablet-Based Retinal Function Test in Neovascular Age-Related Macular Degeneration Eyes and At-Risk Fellow Eye
por: Ho, Chi Yun Doreen, et al.
Publicado: (2018)

Plasma C-C Chemokine Concentrations in Intermediate Age-Related Macular Degeneration
por: Palestine, Alan G., et al.
Publicado: (2021)

Neovascular age-related macular degeneration without exudative recurrence over 24 months after initial remission
por: Cho, Han Joo, et al.
Publicado: (2022)

Proof of Concept, Randomized, Placebo-Controlled Study of the Effect of Simvastatin on the Course of Age-Related Macular Degeneration
por: Guymer, Robyn H., et al.
Publicado: (2013)

Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM study
por: McCarty, Catherine A, et al.
Publicado: (2008)

Age Related Macular Degeneration and Total Hip Replacement Due to Osteoarthritis or Fracture: Melbourne Collaborative Cohort Study
por: Chong, Elaine W., et al.
Publicado: (2015)

Macular Thickness in Intermediate Age-Related Macular Degeneration Is Influenced by Disease Severity and Subretinal Drusenoid Deposit Presence
por: Chiang, Trent Tsun-Kang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s2710c3ts85sj39im5bdp3hagd